Aug 29
|
Expensive Drugs Targeted for First U.S. Price Negotiations
|
Aug 29
|
Biden admin unveils ten drugs picked for Medicare price negotiations
|
Jul 21
|
Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 77% of the company
|
Jul 19
|
12 Highest Yielding Dow Jones Dividend Stocks
|
Jul 19
|
Prediction: This Beaten-Down Stock Will Be a Biotech Giant by 2030
|
Jul 18
|
Softbank, Amgen-Backed Neumora Therapeutics Unveils Plans For Three Phase 3 Studies For Major Depressive Disorder
|
Jul 18
|
Regional banks, Dow Theory: Key technical levels to watch
|
Jul 17
|
Amgen (AMGN) Gains But Lags Market: What You Should Know
|
Apr 30
|
27 Largest Biotech Companies in the US
|
Apr 29
|
Possible bearish signals as Amgen Inc. (NASDAQ:AMGN) insiders disposed of US$5.2m worth of stock
|
Apr 28
|
Amgen (AMGN) Q1 Earnings Beat Estimates, 2023 View Raised
|
Apr 28
|
Why Amgen Shares Are Trading Lower Today
|
Apr 27
|
Amgen (AMGN) Q1 Earnings Beat Estimates
|
Apr 27
|
UPDATE 1-Amgen 1st quarter profit falls as costs rise, sales flatten
|
Apr 27
|
Amgen 1st quarter profit falls as costs rise, sales up 2%
|
Apr 27
|
Amgen 1st quarter profit falls as costs rise, sales flatten
|
Apr 27
|
AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS
|
Apr 26
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
Apr 26
|
14 Best Income Stocks To Invest In
|
Apr 24
|
Can Amgen (AMGN) Keep the Earnings Streak Alive in Q1?
|